PHILADELPHIA (May 14, 2026) — Physicians from the Fox Chase-Temple Urologic Institute will present new research and clinical insights at the 2026 American Urological Association Annual Meeting, where they will highlight advances in kidney cancer treatment, penile prosthesis surgery, and the management of prolonged priapism.
Key Presentations
Advancing Kidney‑Sparing Care for Renal Cell Carcinoma
During the Friday afternoon Plenary Session, Alexander Kutikov, MD, FACS, Chair of Urology at Fox Chase Cancer Center and Co‑Director of the Fox Chase–Temple Urologic Institute, will discuss emerging focal therapy approaches for renal cell carcinoma. A national leader in the management of small renal masses, Kutikov has helped define the role of image‑guided, kidney‑sparing therapies as alternatives to surgery, balancing cancer control with preservation of kidney function.
- Presentation: State‑of‑the‑Art Lecture: The Emerging Role of Focal Therapy in Renal Cell Carcinoma
- Session: Friday, May 15, 1:50–2:05 p.m., Hall D
Rethinking Care for Prolonged Priapism
In the Monday morning Plenary Session, Jay Simhan, MD, FACS, Chair of Urology at Temple University Hospital and the Lewis Katz School of Medicine and Co‑Director of the Fox Chase-Temple Urologic Institute, will discuss modern management of prolonged ischemic priapism, with a focus on early penile prosthesis implantation. A recognized expert in prosthetic urology, Simhan has authored influential guidance on managing post‑priapism complications and complex prosthesis placement.
- Presentation: Second Opinion Case: Prolonged Priapism Management — Is Immediate Prosthesis Now the Standard of Care?
- Session: Monday, May 18, 8:45–9:15 a.m., Hall D
Trending Topics in Urologic Oncology
Predicting Surgical Risk During Penile Prosthesis Placement: Inflatable penile prosthesis surgery is generally safe in experienced hands, but intraoperative complications can affect recovery and long‑term outcomes. Research presented by David Han, MD, a Reconstructive Urology Fellow at the Institute and a Fellow of the Society of Genitourinary Reconstructive Surgeons, uses machine learning to identify patients at higher risk for intraoperative complications before surgery. By analyzing patient health factors and surgical details, this approach supports better surgical planning and clearer, more personalized conversations to improve patient safety.
Preserving Kidney Function While Treating Advanced Kidney Cancer: Treating kidney cancer in patients with chronic kidney disease requires balancing cancer control with kidney preservation. Research led by Benjamin Croll, MD, a Urologic Oncology Fellow at the Institute and a Fellow of the Society of Urologic Oncology, examines the use of medication before surgery to shrink tumors and expand surgical options. Many patients experienced tumor response and stable — or improved — kidney function, suggesting that neoadjuvant therapy may help some patients achieve effective cancer treatment while protecting long‑term kidney health